These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33609554)

  • 1. Inhibition of Glucose Metabolism Abrogates the Effector Phase of Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.
    Schilf P; Schmitz M; Derenda-Hell A; Thieme M; Bremer T; Vaeth M; Zillikens D; Sadik CD
    J Invest Dermatol; 2021 Jul; 141(7):1646-1655.e3. PubMed ID: 33609554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
    Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
    Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
    Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
    Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Leukotriene B
    Sezin T; Krajewski M; Wutkowski A; Mousavi S; Chakievska L; Bieber K; Ludwig RJ; Dahlke M; Rades D; Schulze FS; Schmidt E; Kalies K; Gupta Y; Schilf P; Ibrahim SM; König P; Schwudke D; Zillikens D; Sadik CD
    J Invest Dermatol; 2017 May; 137(5):1104-1113. PubMed ID: 28108297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
    Hellberg L; Samavedam UKSRL; Holdorf K; Hänsel M; Recke A; Beckmann T; Steinhorst K; Boehncke WH; Kirchner T; Möckel N; Solbach W; Zillikens D; Schmidt E; Ludwig RJ; Laskay T
    J Invest Dermatol; 2013 Oct; 133(10):2390-2399. PubMed ID: 23448878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
    Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
    Front Immunol; 2019; 10():3012. PubMed ID: 31993051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita.
    Németh T; Virtic O; Sitaru C; Mócsai A
    J Invest Dermatol; 2017 Oct; 137(10):2131-2139. PubMed ID: 28576735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
    Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
    J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
    Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
    J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
    Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
    J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.
    Wannick M; Assmann JC; Vielhauer JF; Offermanns S; Zillikens D; Sadik CD; Schwaninger M
    Front Immunol; 2018; 9():1890. PubMed ID: 30154797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
    Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
    J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
    Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
    J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita.
    Haeger SC; Kridin K; Pieper M; Griewahn L; Nimmerjahn F; Zillikens D; König P; Ludwig RJ; Hundt JE
    Front Immunol; 2022; 13():938306. PubMed ID: 36311755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options.
    Kasperkiewicz M; Sadik CD; Bieber K; Ibrahim SM; Manz RA; Schmidt E; Zillikens D; Ludwig RJ
    J Invest Dermatol; 2016 Jan; 136(1):24-33. PubMed ID: 26763420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.
    Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ
    Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita.
    Guerrero-Juarez CF; Schilf P; Li J; Zappia MP; Bao L; Patel PM; Gieseler-Tillmann J; Murthy S; Cole C; Sverdlov M; Frolov MV; Hashimoto T; Ishii N; Rülicke T; Bieber K; Ludwig RJ; Sadik CD; Amber KT
    Front Immunol; 2023; 14():1266359. PubMed ID: 37799716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
    Mooney E; Falk RJ; Gammon WR
    Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.